Jacklyn K Jackson1, Amanda J Patterson1, Lesley K MacDonald-Wicks1, Christopher Oldmeadow2, Mark A McEvoy3. 1. Priority Research Centre in Physical Activity and Nutrition, University of Newcastle, Callaghan, New South Wales, Australia. 2. Clinical Research Design and Statistical Services, Hunter Medical Research Institute, University of Newcastle, Callaghan, New South Wales, Australia. 3. Centre for Clinical Epidemiology and Biostatistics, Hunter Medical Research Institute, University of Newcastle, Callaghan, New South Wales, Australia.
Abstract
Context: Depleted nitric oxide levels in the human body play a major role in cardiovascular disease pathogenesis. Inorganic nitrate/nitrite (rich dietary sources include beetroot and spinach) can act as a nitric oxide donor because nitrate/nitrite can be metabolized to produce nitric oxide. Objective: This review and meta-analysis sought to investigate the role of inorganic nitrate/nitrite in preventing or treating cardiovascular disease risk factors in humans. Data Sources: Electronic databases, including Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, Cochrane, and Scopus, were searched. Data Extraction: Experimental trials examining the effect of oral inorganic nitrate/nitrite intake on cardiovascular disease risk factors were included for systematic analysis. Results: Thirty-four studies were included for qualitative synthesis, 23 of which were eligible for meta-analysis. Included studies measured the following outcomes: blood pressure, endothelial function, arterial stiffness, platelet aggregation, and/or blood lipids. Inorganic nitrate intake was found to significantly reduce resting blood pressure (systolic blood pressure: -4.80 mmHg, P < 0.0001; diastolic blood pressure: -1.74 mmHg, P = 0.001), improve endothelial function (flow-mediated dilatation: 0.59%, P < 0.0001), reduce arterial stiffness (pulse wave velocity: -0.23 m/s, P < 0.0001; augmentation index: -2.1%, P = 0.05), and reduce platelet aggregation by 18.9% (P < 0.0001). Conclusions: Inorganic nitrate consumption represents a simple strategy for targeting cardiovascular disease risk factors. Future studies investigating the long-term effects of inorganic nitrate on cardiovascular disease outcomes are warranted.
Context: Depleted nitric oxide levels in the human body play a major role in cardiovascular disease pathogenesis. Inorganic nitrate/nitrite (rich dietary sources include beetroot and spinach) can act as a nitric oxidedonor because nitrate/nitrite can be metabolized to produce nitric oxide. Objective: This review and meta-analysis sought to investigate the role of inorganic nitrate/nitrite in preventing or treating cardiovascular disease risk factors in humans. Data Sources: Electronic databases, including Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, Cochrane, and Scopus, were searched. Data Extraction: Experimental trials examining the effect of oral inorganic nitrate/nitrite intake on cardiovascular disease risk factors were included for systematic analysis. Results: Thirty-four studies were included for qualitative synthesis, 23 of which were eligible for meta-analysis. Included studies measured the following outcomes: blood pressure, endothelial function, arterial stiffness, platelet aggregation, and/or blood lipids. Inorganic nitrate intake was found to significantly reduce resting blood pressure (systolic blood pressure: -4.80 mmHg, P < 0.0001; diastolic blood pressure: -1.74 mmHg, P = 0.001), improve endothelial function (flow-mediated dilatation: 0.59%, P < 0.0001), reduce arterial stiffness (pulse wave velocity: -0.23 m/s, P < 0.0001; augmentation index: -2.1%, P = 0.05), and reduce platelet aggregation by 18.9% (P < 0.0001). Conclusions: Inorganic nitrate consumption represents a simple strategy for targeting cardiovascular disease risk factors. Future studies investigating the long-term effects of inorganic nitrate on cardiovascular disease outcomes are warranted.
Authors: Pedro L Valenzuela; Pedro Carrera-Bastos; Beatriz G Gálvez; Gema Ruiz-Hurtado; José M Ordovas; Luis M Ruilope; Alejandro Lucia Journal: Nat Rev Cardiol Date: 2020-10-09 Impact factor: 32.419
Authors: Mario Siervo; Kirsten Brandt; Othman K Qadir; Chris J Seal; Ammar W Ashor; Michele Tassotti; Pedro Mena; Daniele Del Rio Journal: Eur J Nutr Date: 2022-07-23 Impact factor: 4.865
Authors: Matthew J Rossman; Rachel A Gioscia-Ryan; Jessica R Santos-Parker; Brian P Ziemba; Kara L Lubieniecki; Lawrence C Johnson; Natalie E Poliektov; Nina Z Bispham; Kayla A Woodward; Erzsebet E Nagy; Nathan S Bryan; Julie A Reisz; Angelo D'Alessandro; Michel Chonchol; Amy L Sindler; Douglas R Seals Journal: Hypertension Date: 2021-03-01 Impact factor: 10.190
Authors: Danielle L Kirkman; Austin T Robinson; Matthew J Rossman; Douglas R Seals; David G Edwards Journal: Am J Physiol Heart Circ Physiol Date: 2021-04-09 Impact factor: 5.125
Authors: Oliver M Shannon; Chris Easton; Anthony I Shepherd; Mario Siervo; Stephen J Bailey; Tom Clifford Journal: BMC Sports Sci Med Rehabil Date: 2021-06-07